InvestorsHub Logo
Followers 10
Posts 798
Boards Moderated 0
Alias Born 04/01/2014

Re: wickw50 post# 198462

Monday, 06/10/2024 12:22:58 PM

Monday, June 10, 2024 12:22:58 PM

Post# of 198993
When was the merger agreement of BioClonetics and Enzolytics completed? If the rift in management was caused by the formation of the two subsidiaries, what date were the subsidiaries formed? Did the rift, that was caused by the formation of the subs, cause Charles and Chandra to go silent and prevent them from meeting their stated goals/milestones?

Page 32 and 33 of the latest quarterly report:

On November 30, 2020, the Company consummated the Merger Agreement which involved the formation
of two wholly owned operating subsidiaries, Biogenysis, Inc., (“Biogenysis) and Virogentics, Inc.,
(“Virogentics”). Biogenysis was formed to acquire the intellectual property rights of, and license owned by,
certain officers of BioClonetics Immunotherapeutics, Inc., (“BioClonetics”) and Virogentics which was
formed to acquire the intellectual property rights of and licensed owned by a controlling stockholder of
Enzolytics. Both of the newly formed subsidiaries are Texas Corporations.


https://www.otcmarkets.com/otcapi/company/financial-report/403184/content